Disease, Disability, and Injury Prevention and Control Special Emphasis Panel; Meeting, 61828 [05-21341]
Download as PDF
<![CDATA[
61828
Federal Register / Vol. 70, No. 206 / Wednesday, October 26, 2005 / Notices
Dated: October 17, 2005.
Robert E. Polson,
Office of the Secretary, Paperwork Reduction
Act Reports Clearance Officer.
[FR Doc. 05–21356 Filed 10–25–05; 8:45 am]
BILLING CODE 4168–17–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel; Meeting
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel: Enhancing Utilization
of Childhood Immunization Client
Recall Practices by Private Providers,
RFA; IP 05–088; Improving Vaccination
Coverage in the Greater than 65 Years of
Age Population, RFA IP 05–091;
Influenza Vaccination of Children and
Accompanying Adults: Mass
Vaccination versus Vaccination in
Routine Care, RFA IP 05–094;
Effectiveness of a Hospital Based
Program for Vaccination of Birth
Mothers and Household Contacts with
Inactivated Influenza Vaccine, RFA; IP
05–095; and Developing Methods and
Strategies to Increase Use of
Immunization Registries by Private
Providers, RFA IP 05–096.
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting:
Name: Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Enhancing
Utilization of Childhood Immunization
Client Recall Practices by Private
Providers, RFA IP 05–088; Improving
Vaccination Coverage in the Greater
than 65 Years of Age Population, RFA
IP 05–091; Influenza Vaccination of
Children and Accompanying Adults:
Mass Vaccination versus Vaccination in
Routine Care, RFA IP 05–094;
Effectiveness of a Hospital Based
Program for Vaccination of Birth
Mothers and Household Contacts with
Inactivated Influenza Vaccine, RFA IP
05–095; and Developing Methods and
Strategies to Increase Use of
Immunization Registries by Private
Providers, RFA IP 05–096.
Times and Dates: 8 a.m.–5 p.m.,
November 21, 2005 (Closed).
Place: Renaissance Hotel, 1 Hartsfield
Center Parkway, Atlanta, GA 30354,
Telephone 404.209.9999.
Status: The meeting will be closed to
the public in accordance with
VerDate Aug<31>2005
16:26 Oct 25, 2005
Jkt 208001
provisions set forth in section 552b(c)
(4) and (6), Title 5 U.S.C., and the
Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters to be Discussed: The meeting
will include the review, discussion, and
evaluation of applications received in
response to Enhancing Utilization of
Childhood Immunization Client Recall
Practices by Private Providers, RFA IP
05–088; Improving Vaccination
Coverage in the Greater than 65 Years of
Age Population, RFA IP 05–091;
Influenza Vaccination of Children and
Accompanying Adults: Mass
Vaccination versus Vaccination in
Routine Care, RFA IP 05–094;
Effectiveness of a Hospital Based
Program for Vaccination of Birth
Mothers and Household Contacts with
Inactivated Influenza Vaccine, RFA IP
05–095; and Developing Methods and
Strategies to Increase Use of
Immunization Registries by Private
Providers, RFA IP 05–096.
FOR FURTHER INFORMATION CONTACT:
Horace M. Stiles, PHD MPH DDS,
Scientific Review Administrator,
National Institute for Occupational
Safety and Health, CDC, 1600 Clifton
Road, NE., MS E–74, Atlanta, GA 30333,
Telephone 404–498–2584.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
Dated: October 19, 2005.
Alvin Hall,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 05–21341 Filed 10–25–05; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
Vaccines and Related Biological
Products Advisory Committee; Notice
of Meeting
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
This notice announces a forthcoming
meeting of a public advisory committee
of the Food and Drug Administration
(FDA). At least one portion of the
meeting will be closed to the public.
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
Name of Committee: Vaccines and
Related Biological Products Advisory
Committee.
General Function of the Committee:
To provide advice and
recommendations to the agency on
FDA’s regulatory issues.
Date and Time: The meeting will be
held on November 16, 2005, from 8:30
a.m. to 5:15 p.m. and on November 17,
2005, from 8:30 a.m. to 5:30 p.m.
Location: Holiday Inn Select, 8120
Wisconsin Ave., Bethesda, MD.
Contact Person: Christine Walsh or
Denise Royster, Center for Biologics
Evaluation and Research (HFM–71),
Food and Drug Administration, 1401
Rockville Pike, Rockville, MD 20852,
301–827–0314, or FDA Advisory
Committee Information Line, 1–800–
741–8138 (301–443–0572 in the
Washington, DC area), code
3014512391. Please call the Information
Line for up-to-date information on this
meeting.
Agenda: On November 16, 2005, the
committee will hear presentations and
discuss the use of Madin-Darby Canine
Kidney Cells for manufacture of
Inactivated Influenza Vaccines. On
November 17, 2005, the committee will
discuss developing new Pneumococcal
Vaccines for U.S. licensure for adults.
Procedure: On November 16, 2005,
from 8:30 a.m. to 5:15 p.m. and on
November 17, 2005, from 10 a.m. to 5:30
p.m., the meeting is open to the public.
Interested persons may present data,
information, or views, orally or in
writing, on issues pending before the
committee. Written submissions may be
made to the contact person by
November 9, 2005. Oral presentations
from the public will be scheduled on
November 16, 2005, between
approximately 1:45 p.m. and 2:15 p.m.
and on November 17, 2005, between
approximately 1 p.m. and 1:30 p.m.
Time allotted for each presentation may
be limited. Those desiring to make
formal oral presentations should notify
the contact person before November 9,
2005, and submit a brief statement of
the general nature of the evidence or
arguments they wish to present, the
names and addresses of proposed
participants, and an indication of the
approximate time requested to make
their presentation.
Closed Committee Deliberations: On
November 17, 2005, from 8:30 a.m. to
9:55 a.m., the meeting will be closed to
permit discussion and review of trade
secret and/or confidential information
(5 U.S.C. 552b(c)(4)).
Persons attending FDA’s advisory
committee meetings are advised that the
E:\FR\FM\26OCN1.SGM
26OCN1
]]>Agencies
[Federal Register Volume 70, Number 206 (Wednesday, October 26, 2005)]
[Notices]
[Page 61828]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-21341]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel; Meeting
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel: Enhancing Utilization of Childhood Immunization Client
Recall Practices by Private Providers, RFA; IP 05-088; Improving
Vaccination Coverage in the Greater than 65 Years of Age Population,
RFA IP 05-091; Influenza Vaccination of Children and Accompanying
Adults: Mass Vaccination versus Vaccination in Routine Care, RFA IP 05-
094; Effectiveness of a Hospital Based Program for Vaccination of Birth
Mothers and Household Contacts with Inactivated Influenza Vaccine, RFA;
IP 05-095; and Developing Methods and Strategies to Increase Use of
Immunization Registries by Private Providers, RFA IP 05-096.
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting:
Name: Disease, Disability, and Injury Prevention and Control
Special Emphasis Panel (SEP): Enhancing Utilization of Childhood
Immunization Client Recall Practices by Private Providers, RFA IP 05-
088; Improving Vaccination Coverage in the Greater than 65 Years of Age
Population, RFA IP 05-091; Influenza Vaccination of Children and
Accompanying Adults: Mass Vaccination versus Vaccination in Routine
Care, RFA IP 05-094; Effectiveness of a Hospital Based Program for
Vaccination of Birth Mothers and Household Contacts with Inactivated
Influenza Vaccine, RFA IP 05-095; and Developing Methods and Strategies
to Increase Use of Immunization Registries by Private Providers, RFA IP
05-096.
Times and Dates: 8 a.m.-5 p.m., November 21, 2005 (Closed).
Place: Renaissance Hotel, 1 Hartsfield Center Parkway, Atlanta, GA
30354, Telephone 404.209.9999.
Status: The meeting will be closed to the public in accordance with
provisions set forth in section 552b(c) (4) and (6), Title 5 U.S.C.,
and the Determination of the Director, Management Analysis and Services
Office, CDC, pursuant to Public Law 92-463.
Matters to be Discussed: The meeting will include the review,
discussion, and evaluation of applications received in response to
Enhancing Utilization of Childhood Immunization Client Recall Practices
by Private Providers, RFA IP 05-088; Improving Vaccination Coverage in
the Greater than 65 Years of Age Population, RFA IP 05-091; Influenza
Vaccination of Children and Accompanying Adults: Mass Vaccination
versus Vaccination in Routine Care, RFA IP 05-094; Effectiveness of a
Hospital Based Program for Vaccination of Birth Mothers and Household
Contacts with Inactivated Influenza Vaccine, RFA IP 05-095; and
Developing Methods and Strategies to Increase Use of Immunization
Registries by Private Providers, RFA IP 05-096.
FOR FURTHER INFORMATION CONTACT: Horace M. Stiles, PHD MPH DDS,
Scientific Review Administrator, National Institute for Occupational
Safety and Health, CDC, 1600 Clifton Road, NE., MS E-74, Atlanta, GA
30333, Telephone 404-498-2584.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both CDC and the Agency for Toxic Substances and Disease Registry.
Dated: October 19, 2005.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 05-21341 Filed 10-25-05; 8:45 am]
BILLING CODE 4163-18-P
